by Third Horizon | May 2, 2025 | Life Sciences, Tea Leaves
The Food and Drug Administration (FDA) will survey 250 compounding pharmacies that produce customized versions of prescription drugs, amid ongoing concerns about safety and quality. Compounded drugs, which are not FDA-approved, have surged in popularity, especially...
by Third Horizon | May 2, 2025 | M&A, Tea Leaves
Teladoc has acquired UpLift, a virtual mental health provider, for $30 million in an effort to expand its virtual mental health services despite struggles with its BetterHelp segment. The acquisition, announced alongside Teladoc’s Q1 2025 earnings, aims to improve...
by Third Horizon | May 2, 2025 | Access & Coverage, Tea Leaves
The Department of Health and Human Services (HHS) released a 409-page review claiming gender-affirming care for minors carries significant risks and limited evidence of benefit, contrasting with major medical groups like the American Academy of Pediatrics. The report,...
by Third Horizon | Oct 2, 2024 | Tea Leaves, Tea Leaves Reels, Uncategorized
In this week’s tea leaves reel, David Smith, Founder and CEO, examines the fallout from the Supreme Court’s decision to overturn the Chevron doctrine and its significant impact on health care regulations. As the new Supreme Court term begins on October...
by Third Horizon | Sep 17, 2024 | Tea Leaves, Tea Leaves Reels
This week, Greg Williams, President of Third Horizon, addresses the recent final rule on mental health parity released by the Biden administration. This pivotal update promises to reshape access and coverage for mental health and substance use services, affecting...
by Third Horizon | Sep 10, 2024 | Tea Leaves, Tea Leaves Reels
David Smith, Founder and CEO, explores the shocking downfall of Benefits Data Trust (BDT). After an ambitious plan to scale with AI and a $20M boost, BDT’s rapid decline leaves 250+ employees and countless beneficiaries in the lurch. How did an innovative...
Recent Comments